RAC US FDA Rare Paediatric Disease Designation Granted to
RC220 Bisantrene for the Treatment of Paediatric AML
- Forums
- ASX - Day Trading
- Morning Trading June 18
RAC US FDA Rare Paediatric Disease Designation Granted to RC220...
-
- There are more pages in this discussion • 197 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online